LON:CTEC - ConvaTec Group Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: GBX 253.83
  • Forecasted Upside: 49.23 %
  • Number of Analysts: 7
  • Breakdown:
  • 2 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
GBX 170.10
▲ +1.15 (0.68%)

This chart shows the closing price for CTEC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ConvaTec Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CTEC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CTEC

Analyst Price Target is GBX 253.83
▲ +49.23% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for ConvaTec Group in the last 3 months. The average price target is GBX 253.83, with a high forecast of GBX 310 and a low forecast of GBX 195. The average price target represents a 49.23% upside from the last price of GBX 170.10.

This chart shows the closing price for CTEC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 7 polled investment analysts is to hold stock in ConvaTec Group. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 3 sell ratings
8/3/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 3 sell ratings
11/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 3 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 3 sell ratings
4/30/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 2 sell ratings
7/29/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 2 sell ratings
10/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 2 sell ratings
12/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 2 sell ratings
1/25/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/4/2022JPMorgan Chase & Co.Reiterated RatingOverweight
11/24/2021Royal Bank of CanadaLower Price TargetUnderperformGBX 213 ➝ GBX 195
11/1/2021CitigroupReiterated RatingNeutralGBX 235
11/1/2021JPMorgan Chase & Co.Boost Price TargetOverweightGBX 272 ➝ GBX 278
11/1/2021BarclaysBoost Price TargetOverweightGBX 275 ➝ GBX 290
10/29/2021Shore CapitalReiterated RatingBuy
9/9/2021JPMorgan Chase & Co.UpgradeOverweightGBX 229 ➝ GBX 272
8/10/2021Shore CapitalReiterated RatingBuy
8/9/2021Royal Bank of CanadaDowngradeUnderperformGBX 230 ➝ GBX 213
8/2/2021Credit Suisse GroupBoost Price TargetUnderperformGBX 200 ➝ GBX 215
8/2/2021JPMorgan Chase & Co.Boost Price TargetNeutralGBX 212 ➝ GBX 229
7/30/2021Shore CapitalReiterated RatingBuy
6/23/2021Numis SecuritiesReiterated RatingBuyGBX 310
6/1/2021Royal Bank of CanadaBoost Price TargetSector PerformGBX 200 ➝ GBX 230
5/11/2021Shore CapitalReiterated RatingBuy
4/29/2021Shore CapitalReiterated RatingBuy
3/11/2021Shore CapitalReiterated RatingBuy
11/2/2020Shore CapitalReiterated RatingHold
10/29/2020Credit Suisse GroupBoost Price TargetUnderperformGBX 185 ➝ GBX 190
10/29/2020JPMorgan Chase & Co.Boost Price TargetUnderweightGBX 175 ➝ GBX 176
9/29/2020Royal Bank of CanadaDowngradeSector PerformGBX 245 ➝ GBX 200
7/22/2020BarclaysReiterated RatingEqual weight
7/8/2020BarclaysReiterated RatingEqual weight
7/2/2020Morgan StanleyBoost Price TargetEqual weightGBX 206 ➝ GBX 208
7/2/2020Peel HuntReiterated RatingAdd
6/30/2020JPMorgan Chase & Co.Boost Price TargetUnderweightGBX 167 ➝ GBX 172
6/26/2020Peel HuntDowngradeAddGBX 220 ➝ GBX 225
6/18/2020CitigroupReiterated RatingNeutral
6/10/2020Royal Bank of CanadaUpgradeOutperformGBX 178 ➝ GBX 245
6/3/2020Peel HuntReiterated RatingBuy
5/20/2020Jefferies Financial GroupLower Price TargetBuyGBX 250 ➝ GBX 240
5/18/2020BarclaysBoost Price TargetEqual WeightGBX 182 ➝ GBX 190
5/1/2020CSFBBoost Price TargetUnderperformGBX 175 ➝ GBX 180
5/1/2020JPMorgan Chase & Co.Boost Price TargetUnderweightGBX 160 ➝ GBX 167
5/1/2020Credit Suisse GroupBoost Price TargetUnderperformGBX 175 ➝ GBX 180
5/1/2020UBS GroupBoost Price TargetBuyGBX 235 ➝ GBX 245
4/30/2020Shore CapitalReiterated RatingHold
4/30/2020Peel HuntReiterated RatingBuy
4/24/2020Peel HuntReiterated RatingBuy
4/7/2020Peel HuntReiterated RatingBuy
4/1/2020JPMorgan Chase & Co.Lower Price TargetUnderweightGBX 177 ➝ GBX 160
3/30/2020Peel HuntReiterated RatingBuy
3/20/2020Royal Bank of CanadaLower Price TargetSector PerformerGBX 197 ➝ GBX 178
3/19/2020Peel HuntReiterated RatingBuy
3/12/2020Peel HuntLower Price TargetBuyGBX 250 ➝ GBX 220
3/5/2020Peel HuntReiterated RatingBuy
3/2/2020UBS GroupReiterated RatingBuy
3/2/2020JPMorgan Chase & Co.Boost Price TargetUnderweightGBX 168 ➝ GBX 177
2/24/2020Peel HuntReiterated RatingBuy
2/21/2020UBS GroupReiterated RatingBuy
2/18/2020BarclaysLower Price TargetEqual weightGBX 185 ➝ GBX 182
2/13/2020Peel HuntReiterated RatingBuy
2/5/2020Peel HuntReiterated RatingBuy
2/4/2020JPMorgan Chase & Co.Reiterated RatingUnderweightGBX 168
2/3/2020BarclaysReiterated RatingEqual weight
1/27/2020Peel HuntReiterated RatingBuy
1/23/2020Shore CapitalDowngradeHold
1/21/2020Jefferies Financial GroupBoost Price TargetBuyGBX 220 ➝ GBX 250
1/20/2020JPMorgan Chase & Co.DowngradeUnderweightGBX 171 ➝ GBX 168
1/10/2020UBS GroupUpgradeBuyGBX 185 ➝ GBX 235
1/7/2020Peel HuntReiterated RatingBuy
1/7/2020BarclaysReiterated RatingEqual weight
12/9/2019Royal Bank of CanadaDowngradeSector PerformerGBX 210 ➝ GBX 197
12/5/2019Peel HuntReiterated RatingBuy
11/29/2019Jefferies Financial GroupBoost Price TargetBuyGBX 145 ➝ GBX 220
11/22/2019Shore CapitalReiterated RatingBuy
11/4/2019Peel HuntReiterated RatingBuy
11/1/2019BarclaysBoost Price TargetEqual weightGBX 130 ➝ GBX 185
10/31/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 174 ➝ GBX 171
10/30/2019The Goldman Sachs GroupBoost Price TargetNeutralGBX 118 ➝ GBX 183
10/28/2019UBS GroupReiterated RatingNeutral
10/25/2019Peel HuntReiterated RatingBuyGBX 280
10/25/2019Peel HuntReiterated RatingBuyGBX 280
10/17/2019Credit Suisse GroupDowngradeUnderperform
10/7/2019Peel HuntReiterated RatingBuy
9/18/2019Peel HuntReiterated RatingBuyGBX 280
9/18/2019Peel HuntReiterated RatingBuyGBX 280
9/2/2019Peel HuntReiterated RatingBuy
8/19/2019Peel HuntReiterated RatingBuy
8/12/2019Peel HuntBoost Price TargetBuyGBX 230 ➝ GBX 280
8/6/2019UBS GroupBoost Price TargetNeutralGBX 129 ➝ GBX 185
8/5/2019JPMorgan Chase & Co.Boost Price TargetNeutralGBX 132 ➝ GBX 174
7/29/2019UBS GroupBoost Price TargetNeutralGBX 120 ➝ GBX 129
7/29/2019Peel HuntReiterated RatingBuy
7/22/2019Peel HuntReiterated RatingBuy
7/12/2019Deutsche Bank AktiengesellschaftReiterated RatingSell
7/11/2019Peel HuntReiterated RatingBuy
7/3/2019Peel HuntReiterated RatingBuy
6/4/2019Peel HuntReiterated RatingBuy
5/9/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 135 ➝ GBX 132
5/3/2019Jefferies Financial GroupReiterated RatingBuyGBX 145
5/3/2019Numis SecuritiesReiterated RatingBuyGBX 200
5/2/2019Deutsche Bank AktiengesellschaftLower Price TargetSellGBX 130 ➝ GBX 113
5/2/2019Peel HuntReiterated RatingBuy
4/30/2019CitigroupInitiated CoverageNeutralGBX 138
4/17/2019BarclaysReiterated RatingEqual WeightGBX 148 ➝ GBX 130
4/2/2019Peel HuntReiterated RatingBuy
3/25/2019Peel HuntUpgradeBuyGBX 150 ➝ GBX 230
3/12/2019Peel HuntReiterated RatingHold
2/19/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 160 ➝ GBX 118
2/19/2019UBS GroupLower Price TargetNeutralGBX 150 ➝ GBX 120
2/18/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 192 ➝ GBX 135
2/14/2019Peel HuntReiterated RatingHoldGBX 170 ➝ GBX 150
2/8/2019BarclaysLower Price TargetUnderweightGBX 150 ➝ GBX 148
2/1/2019Peel HuntReiterated RatingHold
1/21/2019Numis SecuritiesReiterated RatingBuyGBX 220
1/18/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 165 ➝ GBX 160
1/4/2019Peel HuntReiterated RatingHold
1/2/2019JPMorgan Chase & Co.Reiterated RatingNeutral
12/10/2018Deutsche Bank AktiengesellschaftLower Price TargetSellGBX 180 ➝ GBX 130
12/6/2018Peel HuntReiterated RatingHold
11/27/2018BarclaysInitiated CoverageUnderweightGBX 150
11/1/2018Peel HuntReiterated RatingHold
10/31/2018Jefferies Financial GroupLower Price TargetBuyGBX 280 ➝ GBX 210
10/26/2018UBS GroupDowngradeNeutralGBX 250 ➝ GBX 150
10/25/2018Peel HuntLower Price TargetHoldGBX 220 ➝ GBX 170
10/16/2018JPMorgan Chase & Co.DowngradeNeutralGBX 280 ➝ GBX 183
10/15/2018Royal Bank of CanadaLower Price TargetOutperformGBX 240 ➝ GBX 210
10/15/2018Numis SecuritiesReiterated RatingHoldGBX 220
10/15/2018Peel HuntReiterated RatingHold
10/5/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
10/3/2018Peel HuntReiterated RatingHold
9/4/2018Peel HuntReiterated RatingHold
8/8/2018Royal Bank of CanadaReiterated RatingOutperformGBX 240
8/3/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
8/2/2018Numis SecuritiesReiterated RatingHold
8/1/2018Peel HuntReiterated RatingHoldGBX 210 ➝ GBX 220
7/4/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
7/3/2018Peel HuntReiterated RatingHold
5/3/2018Credit Suisse GroupBoost Price TargetNeutralGBX 215 ➝ GBX 225
5/3/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
5/2/2018Numis SecuritiesReiterated RatingHoldGBX 180
5/2/2018Peel HuntReiterated RatingHoldGBX 210
4/25/2018Credit Suisse GroupReiterated RatingNeutralGBX 215
4/24/2018Deutsche Bank AktiengesellschaftReiterated RatingSell
4/4/2018Peel HuntReiterated RatingHold
3/26/2018HSBCUpgradeBuyGBX 240 ➝ GBX 238
3/22/2018Royal Bank of CanadaUpgradeOutperformGBX 260 ➝ GBX 240
3/2/2018Peel HuntReiterated RatingHoldGBX 210
3/2/2018Numis SecuritiesReiterated RatingHoldGBX 180
2/23/2018Morgan StanleyReiterated RatingOverweightGBX 249
2/16/2018CitigroupReiterated RatingNeutralGBX 226
2/15/2018Credit Suisse GroupLower Price TargetNeutralGBX 225 ➝ GBX 215
2/15/2018Peel HuntReiterated RatingHoldGBX 250
2/15/2018Numis SecuritiesReiterated RatingHoldGBX 180
2/7/2018Numis SecuritiesUpgradeHoldGBX 180
2/1/2018Peel HuntReiterated RatingHoldGBX 250
12/5/2017Numis SecuritiesReiterated RatingReduceGBX 180
12/1/2017Deutsche Bank AktiengesellschaftReiterated RatingSellGBX 180
10/31/2017Peel HuntReiterated RatingHoldGBX 250
10/18/2017Numis SecuritiesUpgradeReduceGBX 180
10/17/2017Credit Suisse GroupLower Price TargetNeutralGBX 280 ➝ GBX 225
10/17/2017Peel HuntDowngradeHoldGBX 390 ➝ GBX 250
10/17/2017CitigroupLower Price TargetNeutralGBX 290 ➝ GBX 226
10/16/2017Numis SecuritiesDowngradeSellGBX 220
10/11/2017CitigroupReiterated RatingNeutralGBX 290
9/20/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 303
9/11/2017The Goldman Sachs GroupReiterated RatingBuyGBX 330
8/21/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuyGBX 330 ➝ GBX 335
8/9/2017Peel HuntBoost Price TargetBuyGBX 380 ➝ GBX 390
8/9/2017Numis SecuritiesLower Price TargetReduceGBX 260 ➝ GBX 250
8/6/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 330
8/4/2017JPMorgan Chase & Co.Lower Price TargetOverweightGBX 318 ➝ GBX 303
8/3/2017Numis SecuritiesReiterated RatingReduceGBX 260
8/3/2017The Goldman Sachs GroupReiterated RatingBuyGBX 340
8/3/2017Peel HuntReiterated RatingBuyGBX 380
7/31/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 330
7/20/2017Peel HuntReiterated RatingBuyGBX 380
7/11/2017Numis SecuritiesDowngradeReduceGBX 276 ➝ GBX 260
6/30/2017The Goldman Sachs GroupReiterated RatingBuyGBX 340
5/15/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 330
5/8/2017Deutsche Bank AktiengesellschaftReiterated RatingBuyGBX 330
5/5/2017JPMorgan Chase & Co.Boost Price TargetOverweightGBX 305 ➝ GBX 318
5/5/2017Credit Suisse GroupBoost Price TargetNeutralGBX 275 ➝ GBX 290
5/4/2017Numis SecuritiesReiterated RatingHoldGBX 276
5/4/2017Morgan StanleyReiterated RatingEqual weight
5/4/2017The Goldman Sachs GroupReiterated RatingBuyGBX 310
5/4/2017Peel HuntBoost Price TargetBuyGBX 300 ➝ GBX 380
4/4/2017Numis SecuritiesReiterated RatingHoldGBX 276
3/30/2017JPMorgan Chase & Co.Reiterated RatingOverweightGBX 305
3/23/2017Royal Bank of CanadaBoost Price Targetsector performGBX 242 ➝ GBX 278
3/21/2017The Goldman Sachs GroupReiterated RatingBuyGBX 310
3/7/2017The Goldman Sachs GroupBoost Price TargetBuyGBX 300 ➝ GBX 310
3/6/2017Deutsche Bank AktiengesellschaftBoost Price TargetBuyGBX 275 ➝ GBX 300
3/3/2017JPMorgan Chase & Co.Boost Price TargetOverweightGBX 271 ➝ GBX 305
3/3/2017Credit Suisse GroupBoost Price TargetNeutralGBX 250 ➝ GBX 275
3/2/2017Peel HuntReiterated RatingBuyGBX 300
2/27/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy
2/24/2017Peel HuntReiterated RatingBuyGBX 300
(Data available from 1/26/2017 forward)

News Sentiment Rating

-0.47 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/26/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
ConvaTec Group logo
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urological catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products use in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to the manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospitals and the home healthcare sector. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.
Read More

Today's Range

Now: GBX 170.10
Low: 169.70
High: 172.10

50 Day Range

MA: GBX 190.62
Low: 166.85
High: 220.74

52 Week Range

Now: GBX 170.10
Low: 165.85
High: 265

Volume

1,125,788 shs

Average Volume

2,713,353 shs

Market Capitalization

£3.43 billion

P/E Ratio

34.02

Dividend Yield

2.44%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ConvaTec Group?

The following equities research analysts have issued reports on ConvaTec Group in the last year: Barclays PLC, Citigroup Inc., Credit Suisse Group AG, JPMorgan Chase & Co., Numis Securities Ltd, Royal Bank of Canada, and Shore Capital.
View the latest analyst ratings for CTEC.

What is the current price target for ConvaTec Group?

6 Wall Street analysts have set twelve-month price targets for ConvaTec Group in the last year. Their average twelve-month price target is GBX 253.83, suggesting a possible upside of 49.2%. Numis Securities Ltd has the highest price target set, predicting CTEC will reach GBX 310 in the next twelve months. Royal Bank of Canada has the lowest price target set, forecasting a price of GBX 195 for ConvaTec Group in the next year.
View the latest price targets for CTEC.

What is the current consensus analyst rating for ConvaTec Group?

ConvaTec Group currently has 2 sell ratings, 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CTEC, but not buy more shares or sell existing shares.
View the latest ratings for CTEC.

How do I contact ConvaTec Group's investor relations team?

ConvaTec Group's physical mailing address is 3 Forbury Place Floor 7, 23 Forbury Road, ICKENHAM, RG1 3JH, United Kingdom. The company's listed phone number is 44 11 8952 8100. The official website for ConvaTec Group is www.convatecgroup.com.